About Careers Internship MedBlog Contact us

Cameron Warns Against Protectionism, but Asks for Pfizer Assurance on AstraZeneca Takeover

by Kathy Jones on May 9, 2014 at 10:25 PM
Font : A-A+

 Cameron Warns Against Protectionism, but Asks for Pfizer Assurance on AstraZeneca Takeover

Even as David Cameron backed foreign investment, saying that it would be beneficial for Britain and warning the country from turning towards protectionism, the British Prime Minister asked US pharmaceutical giant Pfizer to provide more assurances that its takeover bid for AstraZeneca would be in his country's national interest.

But he told parliament that the US firm had yet to convince him that the purchase of a company employing 6,700 people in Britain would be in the national interest.


Facing questions in the House of Commons, Cameron said the commitments made so far -- including retaining at least 20 percent of the research and development workforce in Britain -- were "encouraging".

He said: "Let me be absolutely clear, I'm not satisfied, I want more. But the way to get more is to engage, not to stand up and play party politics." .

He added: "The more we can do to strengthen the assurances the better."

AstraZeneca has so far rebuffed approaches from Pfizer, but Pfizer has hinted that it could launch a hostile takeover if the stalemate persists.

A deal around the £60 billion ($101.8 billion) mark would be the biggest ever foreign takeover of a British company.

Cameron dismissed suggestions from the leader of the main opposition Labour Party, Ed Miliband, that he was "cheerleading" for the deal by instructing cabinet ministers to discuss the situation with both companies.

He said he agreed with the position taken by Business Secretary Vince Cable, who refused on Tuesday to rule out intervening to block a formal bid.

"The most important intervention we can make is to back British jobs, British science, British R&D, British medicines and British technology," Cameron said.

"We know what happens when you do not engage"

"We are fighting for British science and I just think it is a pity that he (Miliband) is trying to play politics rather than backing the British national interest."

Source: AFP


Latest Corporate News

 Global Report of Work-related Diseases
The first World Health Organisation (WHO)/ International Labour Organisation (ILO) joint global monitoring report shows that more action is needed to ensure healthier, safer, more resilient, and more social workplaces.
New AI Tool Could Ensure Smooth Job Transitions
Successful career transitions could be possible when people leverage their existing skills in the new occupation. A new Artificial Intelligence tool helps employees figure out the right job according to their current skill set.
 Recent Improvements In Pharmaceutical Sector
AI and big data rule the pharmaceutical sector by enhancing the drug development process and increasing the marketing and sales of drugs
Food to be Covered by Insurance Soon
Insurance companies in the US are working towards adding food to their coverage menu to improve the people's health under their coverage and cut hospital costs.
Pharma Companies Have to Support or Risk Damaging Global Reputation
Pharmaceutical companies need to make strategic decisions that will provide financial benefit while showing strong commitment to global health and their patients during the pandemic.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Cameron Warns Against Protectionism, but Asks for Pfizer Assurance on AstraZeneca Takeover Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests